Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

被引：0
|
作者：
Maraka, Stefania
Groves, Morris D.
Mammoser, Aaron Gerald
Melguizo-Gavilanes, Isaac
Conrad, Charles A.
Tremont-Lukats, Ivo
Loghin, Monica Elena
O'Brien, Barbara Jane
Puduvalli, Vinay K.
Sulman, Erik P.
Hess, Kenneth R.
Aldape, Kenneth D.
Gilbert, Mark R.
De Groot, John Frederick
Yung, W. K. Alfred
Penas-Prado, Marta
机构：
[1] Univ Texas MD Anderson Canc Ctr, Neurooncol Dept, Houston, TX USA
[2] LSU Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA USA
[3] Aurora Canc Care Neurooncol, Milwaukee, WI USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Houston Methodist Hosp, Neurooncol, Neurol, Houston, TX USA
[6] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[7] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2044
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma
    Maraka, Stefania
    Groves, Morris D.
    Mammoser, Aaron G.
    Melguizo-Gavilanes, Isaac
    Conrad, Charles A.
    Tremont-Lukats, Ivo W.
    Loghin, Monica E.
    Obrien, Barbara J.
    Puduvalli, Vinay K.
    Sulman, Erik P.
    Hess, Kenneth R.
    Aldape, Kenneth D.
    Gilbert, Mark R.
    de Groot, John F.
    Yung, W. K. Alfred
    Penas-Prado, Marta
    CANCER, 2019, 125 (03) : 424 - 433
  • [2] Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma (vol 125, pg 424, 2018)
    Maraka, S.
    Groves, M. D.
    Mammoser, A. G.
    CANCER, 2019, 125 (08) : 1387 - 1387
  • [3] PHASE I STUDY OF VANDETANIB WITH RADIATION THERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
    Drappatz, Jan
    Norden, Andrew
    Wong, Eric T.
    Doherty, Lisa
    LaFrankie, Debra
    Ciampa, Abigail
    Kesari, Santosh
    Sceppa, Christine
    Gerard, Mary
    Phan, Phuong
    Lassman, Andrew B.
    Schiff, David
    Batchelor, Tracy
    Ligon, Keith L.
    Young, Geoffrey
    Muzikansky, Alona
    Weiss, Stephanie
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [4] Phase I study of vandetanib with radiation therapy and temozolomide for newly diagnosed glioblastoma
    Drappatz, J.
    Norden, A. D.
    Wong, E. T.
    Lassman, A. B.
    Doherty, L.
    LaFrankie, D.
    Gerard, M.
    Phan, P.
    Schiff, D.
    Wen, P. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Phase I study of ruxolitinib with radiation and temozolomide in patients with newly diagnosed grade III gliomas and glioblastoma.
    Rauf, Yasmeen
    Hufsey, Rachel
    Robinson, Kathy
    Suh, John H.
    Chao, Samuel T.
    Murphy, Erin Sennett
    Yu, Jennifer S.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    Wei, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Ahluwalia, Manmeet S.
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Figel, Sheila A.
    Mechtler, Laszlo L.
    Peereboom, David M.
    Hutson, Alan D.
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed N.
    Qiu, Jingxin
    Mogensen, Kathleen M.
    Dharma, Sanam S.
    Dhawan, Andrew
    Birkemeier, Meaghan T.
    Casucci, Danielle M.
    Ciesielski, Michael J.
    Fenstermaker, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1453 - +
  • [7] A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
    Huang, Jiayi
    DeWees, Todd
    Campian, Jian Li
    Chheda, Milan G.
    Ansstas, George
    Tsien, Christina
    Zipfel, Gregory J.
    Dunn, Gavin P.
    Ippolito, Jospeh E.
    Cairncross, J. Gregory
    Easaw, Jacob C.
    Rubin, Josh
    Kim, Albert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Phase III TRIDENT trial: Radiation and temozolomide plus /- tumor treating fields in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel Aaron
    Nagpal, Seema
    Reardon, David A.
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] A PHASE I STUDY OF SORAFENIB WITH RADIATION AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Colman, Howard
    Gilbert, Mark
    Yung, W. K. Alfred
    Aldape, Ken
    De Groot, John
    Conrad, Charles
    Levin, Victor
    Groves, Morris
    Loghin, Monica
    Chris, Pelloski
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2011, 13 : 61 - 61
  • [10] A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Fiveash, John
    Nabors, Louis B.
    Mikkelsen, Tom
    Peereboom, David M.
    Lesser, Glenn J.
    Chowdhary, Sajeel A.
    Grossman, Stuart
    Ye, Xiaubu
    Leopold, Lance
    Rosenfeld, Myrna
    NEURO-ONCOLOGY, 2009, 11 (05) : 666 - 666
12345